Zobrazeno 1 - 1
of 1
pro vyhledávání: '"22/24"'
Autor:
Brian D. Kent, Mariana Fernandes, Cris Roxas, Louise Thompson, Joanne Kavanagh, David A. Jackson, Alexandra Nanzer-Kelly, Grainne D'Ancona, L. Green
Publikováno v:
Airway pharmacology and treatment.
Introduction: Benralizumab is a monoclonal antibody against IL-5R and is licensed for the treatment of severe eosinophilic asthma (SEA). It is appreciated that there are sub-phenotypes of SEA relating to both atopy and age of onset. However, whether